Caballero, Adelaida B.
HRN: 22-82-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2023
CEFTRIAXONE 1G (VIAL)
04/08/2023
04/14/2023
IV
1g
Q12
Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes